Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers-Reference-Cited by-同舟云学术

Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers

Published:2011-11-10 Issue:1 Volume:226 Page:7-16
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Yip Stephen,Butterfield Yaron S,Morozova Olena,Chittaranjan Suganthi,Blough Michael D,An Jianghong,Birol Inanc,Chesnelong Charles,Chiu Readman,Chuah Eric,Corbett Richard,Docking Rod,Firme Marlo,Hirst Martin,Jackman Shaun,Karsan Aly,Li Haiyan,Louis David N,Maslova Alexandra,Moore Richard,Moradian Annie,Mungall Karen L,Perizzolo Marco,Qian Jenny,Roldan Gloria,Smith Eric E,Tamura-Wells Jessica,Thiessen Nina,Varhol Richard,Weiss Samuel,Wu Wei,Young Sean,Zhao Yongjun,Mungall Andrew J,Jones Steven JM,Morin Gregg B,Chan Jennifer A,Cairncross J Gregory,Marra Marco A

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference52 articles.

1. Chemosensitive gliomas in adults: which ones and why?;Mason;J Clin Oncol,1997

2. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas;Cairncross;J Natl Cancer Inst,1998

3. The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors;McDonald;Cancer,2005

4. Anaplastic oligodendrogliomas with 1p/19q codeletion have a proneural gene expression profile;Ducray;Mol Cancer,2008

Cited by 271 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic Alterations in Molecularly Defined Oligodendrogliomas;Neurosurgery;2024-07-15

2. The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?;Neuro-Oncology;2024-06-24

3. Molecular Pathology of Gliomas;Clinics in Laboratory Medicine;2024-06

4. Isocitrate Dehydrogenase Inhibitors in Glioma: From Bench to Bedside;Pharmaceuticals;2024-05-26

5. IDH inhibition in gliomas: from preclinical models to clinical trials;Nature Reviews Neurology;2024-05-17